Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookies. More details and information can be found in our Data Privacy Statement – please refer to this to adjust your settings for website analytics tracking (e.g. enable/disable). By closing this window you agree to our standard Terms of Use.

I'm ok with this

Placebo Effect and Pain - Part 2 | PainSolve
;

Updates & Features

Placebo Effect and Pain - Part 2

June 2018

Future directions to minimise ‘false negatives’ in pain trials

PainSolve Editorial Team

Given that there is a measurable placebo response in pain and that the impact of this effect may be increasing over time, there is considerable interest in adapting pain clinical trial methodologies and designs to reduce the likelihood of ‘false negative’ trial outcomes due to large pain reductions in the placebo group.1 Several strategies have been proposed for this (see table 1 below):

Like
 
Share

Share this with:

These are external links and will open in a new window